All lobbying filings

Forbes-Tate

Forbes-Tate filed a Q3 termination report for Hopewell Fund on October 10, 2025.

Lobbying for Hopewell Fund · Preserving access to medication abortion care.

As filed: FORBES-TATE for HOPEWELL FUND.

All filings by Forbes-Tate · Everything Hopewell Fund has reported

Filing · LD-2 quarterly report Q3 termination

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 10, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

District of Columbia

Representation ended

Jul 1, 2025

The registrant reported terminating its work for this client.

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to FDA approved medicines.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.